Papareddy, Praveen http://orcid.org/0000-0002-3872-478X
Rossnagel, Madlen
Doreen Hollwedel, Femke
Kilic, Gülcan
Veerla, Srinivas
Naudin, Clément http://orcid.org/0000-0002-6777-9587
Smeds, Emanuel
Westman, Johannes http://orcid.org/0000-0001-6998-3939
Martinez-Martinez, Irene
Egesten, Arne
de la Morena-Barrio, Maria Eugenia http://orcid.org/0000-0001-7426-4947
Corral, Javier
Linder, Adam
Artoni, Andrea
Abbattista, Maria
Novembrino, Cristina
Herbert Brakebusch, Cord
Martinelli, Ida
Kasetty, Gopinath
Herwald, Heiko http://orcid.org/0000-0002-8111-2842
Funding for this research was provided by:
Crafoordska Stiftelsen (20180506)
Alfred Österlund Foundation
Knut och Alice Wallenbergs Stiftelse (2011.0037)
Stiftelsen för Strategisk Forskning (SB12-0019)
Vetenskapsrådet (2016-01104)
Lund University | Medicinska Fakulteten, Lunds Universitet
Article History
Received: 25 March 2019
Accepted: 8 August 2019
First Online: 23 September 2019
Competing interests
: P.P., A.E., G.K. and H.H. have filed a provisional patent on the possibility of using hβAT as an antimicrobial treatment. All other authors have no competing interests.